Massimo, which provides devices for monitoring, is acquiring NantHealth's division which offers software and services around interoperability and data connections for medical devices, for about $47 million.
Telemedicine vendor Teladoc is acquiring InTouch Health, a competitor, for $600 million. For that price it gets only about $80 million in revenue. This is a typical trajectory and one that should concern investors. Telemedicine has potential and can add value to the system but it is highly hyped. So companies feed on that hype, get a high value, can't really generate the revenue, or certainly the profit expected, and then start doing acquisitions to divert attention and try to create something that can generate a return.
Medicaid health plan Molina is acquiring NextLevel Health Partners, a Chicago-based Medicaid plan with around 50,000 members. The purchase price was about $50 million.
As seems to often be the case these days, at least until Elizabeth Warren is elected, a health care business is being sold by one private equity firm to another, this time it is EyeCare Partners, going for about $2.2 billion.
Two providers of health trauma registries are combining, as ESO, which also sells a variety of emergency medical services related software, is acquiring Clinical Data Management.
A private equity firm has combined two firms specializing in delivering pharmacy services to patients served by community health centers--Long's Drugs and PharMedQuest Pharmacy Services.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.